No Mercy / No Malice: Seconds

Food Impact

The introduction of GLP-1 drugs is reshaping the food industry, particularly impacting fast food and snack sectors. Scott Galloway highlights that these medications are causing a decline in fast food consumption, with 77% of surveyed Ozempic users visiting fast food restaurants less often 1. This shift is already affecting stock market trends, as traders anticipate a $25 billion revenue hit to the restaurant industry by 2025.

Fast food gets hit first, but fast casual is also under threat. Look for snack foods, frozen meals, candy, soda, and baked goods to all take a hit.

--- Scott Galloway

The broader implications of reduced obesity rates extend beyond food sales, potentially influencing sectors like apparel and fitness 2.

   

Airlines & Fitness

Weight loss trends driven by GLP-1 drugs are poised to affect the airline and fitness industries. Scott Galloway notes that United Airlines could save $80 million annually in fuel costs if passengers lost an average of ten pounds 1. This potential for savings highlights the far-reaching economic impacts of population-wide weight loss.

Sports and fitness will be restructured. Gyms built on a consumer base trying to lose weight will see lower revenue, whereas sports for which fitness is a prerequisite, skiing, mountain biking, climbing, stand to benefit.

--- Scott Galloway

Additionally, the fitness sector may experience shifts, with traditional gyms seeing decreased revenue while sports requiring fitness may gain popularity 1.